心脏瓣膜介入治疗新器械专题会 XI

Symposium on Novel Devices for Cardiac Valve Interventional Therapy XI

04/18 15:40-17:40

杭州厅6&7 (Room Hangzhou 6&7)

15:40-17:40

名誉主席

Honorary Chair
15:40-17:40

主席

Chairman
15:40-17:40

主持

Moderator
15:40-17:40

讨论嘉宾

Panelist
15:40-16:20

疗法方向之争：低龄时代是否已经到来？

Debate on Therapeutic Direction: Has the Era of Younger Patients Arrived?
15:40-15:41

开场致辞

Opening Remarks
15:40-15:48

ESC瓣膜性心脏病管理指南解读

Interpretation of the ESC Guidelines for the Management of Valvular Heart Disease
15:48-15:56

TAVR低龄低危适应证循证

Evidence for TAVR in Low-risk, Younger Patients: Expanding Indications
15:56-16:06

ESC指南发布后，欧洲TAVR真实世界应用情况

Real-World Application of TAVR in Europe Following the ESC Guidelines Update
16:06-16:16

ESC指南发布后，南美洲TAVR真实世界应用情况

Real-World Application of TAVR in Latin America Following the ESC Guidelines Update
16:16-16:20

问答

Q&A
16:20-17:05

技术路径之争：自膨 vs 球扩谁更有优势？

Debate on Technical Path: Self-Expandable Valve vs. Balloon-Expandable Valve, Which Is More Advantageous?
16:20-16:25

升主扩张合并极低EF值伴心肌致密化不全TAVR一例

A Case of TAVR in Ascending Aortic Dilation Combined with Extremely Low Ejection Fraction and Noncompaction Cardiomyopathy
16:25-16:35

讨论

Discussion
16:35-16:40

冠脉高风险风湿性主动脉瓣狭窄一例

A Case of Rheumatic Aortic Stenosis with High Coronary Risk
16:40-16:50

讨论

Discussion
16:50-16:55

重度主动脉瓣狭窄急诊TAVR一例

A Case of Emergency TAVR for Severe Aortic Stenosis
16:55-17:05

讨论

Discussion
17:05-17:40

肺瓣专场

Pulmonary Valve Special Session
17:05-17:15

肺瓣患者全生命周期管理

Lifecycle Management of Patients with Pulmonary Valve Disease
17:15-17:20

讨论

Discussion
17:20-17:30

VenusP-Valve在复杂病例中的应用

Application of VenusP-Valve in Complex Cases
17:30-17:35

讨论

Discussion
17:35-17:40

致结束语

Closing Remarks

打印